Insider Transactions in Q1 2022 at Perrigo CO PLC (PRGO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 14
2022
|
Thomas Farrington EVP and CIO |
SELL
Open market or private sale
|
Indirect |
2,259
-100.0%
|
$83,583
$37.23 P/Share
|
|
Mar 14
2022
|
Thomas Farrington EVP and CIO |
SELL
Open market or private sale
|
Direct |
24,485
-100.0%
|
$905,945
$37.13 P/Share
|
|
Mar 07
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Open market or private sale
|
Direct |
3,954
-20.13%
|
$142,344
$36.73 P/Share
|
|
Mar 04
2022
|
Svend Andersen EVP & President CHCI |
SELL
Payment of exercise price or tax liability
|
Direct |
1,289
-0.93%
|
$47,693
$37.23 P/Share
|
|
Mar 04
2022
|
Svend Andersen EVP & President CHCI |
BUY
Exercise of conversion of derivative security
|
Direct |
8,911
+7.17%
|
$329,707
$37.23 P/Share
|
|
Mar 04
2022
|
Svend Andersen EVP & President CHCI |
BUY
Grant, award, or other acquisition
|
Direct |
14,503
+30.08%
|
$536,611
$37.23 P/Share
|
|
Mar 04
2022
|
Raymond Silcock EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,628
-5.03%
|
$319,236
$37.23 P/Share
|
|
Mar 04
2022
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,502
+6.91%
|
$314,574
$37.23 P/Share
|
|
Mar 04
2022
|
Raymond Silcock EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,422
+25.38%
|
$718,614
$37.23 P/Share
|
|
Mar 04
2022
|
Murray S Kessler CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
52,595
-10.88%
|
$1,946,015
$37.23 P/Share
|
|
Mar 04
2022
|
Murray S Kessler CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,328
+12.44%
|
$1,825,136
$37.23 P/Share
|
|
Mar 04
2022
|
Murray S Kessler CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,286
+39.35%
|
$2,970,582
$37.23 P/Share
|
|
Mar 04
2022
|
Grainne Quinn EVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,135
-10.48%
|
$189,995
$37.23 P/Share
|
|
Mar 04
2022
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,862
+10.03%
|
$142,894
$37.23 P/Share
|
|
Mar 04
2022
|
Grainne Quinn EVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,008
+32.01%
|
$222,296
$37.23 P/Share
|
|
Mar 04
2022
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
8,300
-8.79%
|
$307,100
$37.23 P/Share
|
|
Mar 04
2022
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
7,002
+9.33%
|
$259,074
$37.23 P/Share
|
|
Mar 04
2022
|
James E Dillard Iii EVP & President CSCA |
BUY
Grant, award, or other acquisition
|
Direct |
11,395
+31.98%
|
$421,615
$37.23 P/Share
|
|
Mar 04
2022
|
Todd W Kingma Executive VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
10,001
-5.47%
|
$370,037
$37.23 P/Share
|
|
Mar 04
2022
|
Todd W Kingma Executive VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,911
+6.22%
|
$329,707
$37.23 P/Share
|
|
Mar 04
2022
|
Todd W Kingma Executive VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
14,503
+23.83%
|
$536,611
$37.23 P/Share
|
|
Mar 04
2022
|
Orlando D Ashford Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,433
-48.02%
|
$53,021
$37.23 P/Share
|
|
Mar 04
2022
|
Orlando D Ashford Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,984
+50.0%
|
$110,408
$37.23 P/Share
|
|
Mar 04
2022
|
Thomas Farrington EVP and CIO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,966
-5.02%
|
$183,742
$37.23 P/Share
|
|
Mar 04
2022
|
Thomas Farrington EVP and CIO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,424
+5.74%
|
$163,688
$37.23 P/Share
|
|
Mar 04
2022
|
Thomas Farrington EVP and CIO |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+22.34%
|
$266,400
$37.23 P/Share
|
|
Mar 04
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,306
-7.85%
|
$233,322
$37.23 P/Share
|
|
Mar 04
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,410
+8.49%
|
$200,170
$37.23 P/Share
|
|
Mar 04
2022
|
Ronald Craig Janish EVP, Gbl Ops & SC & CTO |
BUY
Grant, award, or other acquisition
|
Direct |
8,805
+30.01%
|
$325,785
$37.23 P/Share
|
|
Mar 04
2022
|
Robert Willis EVP & CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,209
-9.28%
|
$192,733
$37.23 P/Share
|
|
Mar 04
2022
|
Robert Willis EVP & CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,012
+10.17%
|
$185,444
$37.23 P/Share
|
|
Mar 04
2022
|
Robert Willis EVP & CHRO |
BUY
Grant, award, or other acquisition
|
Direct |
4,999
+25.06%
|
$184,963
$37.23 P/Share
|
|
Feb 07
2022
|
James E Dillard Iii EVP & President CSCA |
SELL
Payment of exercise price or tax liability
|
Direct |
2,059
-13.82%
|
$74,124
$36.95 P/Share
|
|
Feb 07
2022
|
James E Dillard Iii EVP & President CSCA |
BUY
Exercise of conversion of derivative security
|
Direct |
4,297
+22.38%
|
$154,692
$36.95 P/Share
|